mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.2 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.2 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.2 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.2 |